In contrast, our patients exhibited similarly low median percentages of IgD+CD27+ memory B cells (8.6% and 6.8% for responders and non-responders, respectively) as described for patients with long-standing RA (10.4%). The gene discussed is CD27; the disease is rheumatoid arthritis.